Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

NCT01226511 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01226511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01226511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2011
Completion date
June 30, 2013
Enrollment
281 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety neuroses, anxiety states, neurotic, neuroses, anxiety